Search

everythinglearnresearchcommunity

for

Search:↓

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

Cedrol may be an effective treatment for colorectal cancer.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Finasteride use may increase the risk of male breast cancer.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.